scholarly journals Withdrawal: Blockade of Fas signaling in breast cancer cells suppresses tumor growth and metastasis via disruption of Fas signaling-initiated cancer-related inflammation

2021 ◽  
Vol 296 ◽  
pp. 100757
Author(s):  
Qiuyan Liu ◽  
Qinchun Tan ◽  
Yuanyuan Zheng ◽  
Kun Chen ◽  
Cheng Qian ◽  
...  
2011 ◽  
Vol 29 (10) ◽  
pp. 676-682 ◽  
Author(s):  
Michael Opoku-Darko ◽  
Carol Yuen ◽  
Katherine Gratton ◽  
Elliot Sampson ◽  
Oliver F. Bathe

2014 ◽  
Vol 2014 ◽  
pp. 1-11 ◽  
Author(s):  
Youn Kyung Choi ◽  
Sung-Gook Cho ◽  
Sang-Mi Woo ◽  
Yee Jin Yun ◽  
Sunju Park ◽  
...  

Cancer inflammation promotes cancer progression, resulting in a high risk of cancer. Here, we demonstrate that our new herbal extract, SH003, suppresses both tumor growth and metastasis of MDA-MB-231 breast cancer cells via inhibiting STAT3-IL-6 signaling path. Our new herbal formula, SH003, mixed extract fromAstragalus membranaceus, Angelica gigas, andTrichosanthes kirilowiiMaximowicz, suppressed MDA-MB-231 tumor growth and lung metastasisin vivoand reduced the viability and metastatic abilities of MDA-MB-231 cellsin vitro. Furthermore, SH003 inhibited STAT3 activation, which resulted in a reduction of IL-6 production. Therefore, we conclude that SH003 suppresses highly metastatic breast cancer growth and metastasis by inhibiting STAT3-IL-6 signaling path.


Sign in / Sign up

Export Citation Format

Share Document